We put patients and people before profit.
We value the health and wellbeing of patients above all else. This drives our commitment to accelerating patient access to medicines and healthcare technology.
Our team is made up of the best consultants in the industry. They have backgrounds and experience across every step of the Market Access process, meaning you receive the best expertise and care through every step of your journey. We are an active member of key trade groups and have helped clients with over 200 HTA submissions across international markets.
Our integrated approach through MAP Online and our consultancy service provides a flexible offer. We help find the answers you need in a cost-effective way. We know that turning to consultants to answer every question can quickly add up and that is why we created MAP Online.
It provides extensive information, coupled with the MAP Online team who are on hand to answer any questions. It will help you plan out your Market Access journey in full and if you then need assistance putting it into practice our team of consultants are on hand. Also, with a MAP Online membership you get 10% discount on consultancy projects.
MAP Online is the only validated Market Access knowledge portal providing a single source of information, backed by expert support, and enhanced with insight from our team of consultants. It also offers extra value with downloadable tools and essential resources to help you plan your Market Access journey. Bringing your treatment to market requires a massive amount of information. MAP Online makes this easy by gathering all the information into one place and helps you find the exact pieces that are the most use to you.
One of the challenges of Market Access is knowing you have the complete picture. Our team continually monitor and track new developments and changes to the Market Access process, updating MAP Online continuously so you can rely on us to keep you up to speed.
MAP BioPharma plays an active role in the discussion and debate regarding access to medicines globally. Through our work in the UK, supported by a number of MAP Online members, we have helped to shine a light on inequalities in the way that orphan medicines are assessed.
MAP BioPharma provides a unique integrated consultancy that covers Market Access, policy & public affairs and legal perspectives and helps to join up the dots. We provide our clients with a strategic perspective of their Market Access process which prevents missed steps and costly delays.
Copyright © 2021. MAP BioPharma Limited. All rights reserved.
MAP BioPharma Limited
Upper Pendrill Court, Ermine Street North
Papworth Everard, Cambridge
Cambridgeshire, CB23 3UY
MAP BioPharma Limited is a registered company in England and Wales.
Company Registration Number 08209281
VAT Group Registration Number GB 292 8576 52